Literature DB >> 14718713

Pilot trial of 1-octanol in essential tremor.

K O Bushara1, S R Goldstein, G J Grimes, A H Burstein, M Hallett.   

Abstract

1-Octanol (an 8-C alcohol currently used as a food-flavoring agent) is known to inhibit tremor in essential tremor (ET) animal models at a much lower dose than ethyl alcohol. The authors conducted a randomized, placebo-controlled pilot trial of a single oral dose of 1 mg/kg of 1-octanol in 12 patients with ET. No significant side effects or signs of intoxication were observed. 1-Octanol significantly decreased tremor amplitude for up to 90 minutes. The results suggest 1-octanol as a well-tolerated and safe potential treatment for ET. Further trials are warranted.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718713     DOI: 10.1212/01.wnl.0000101722.95137.19

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Review on clinical update of essential tremor.

Authors:  Wei Chunling; Xiao Zheng
Journal:  Neurol Sci       Date:  2016-01-09       Impact factor: 3.307

Review 2.  Pharmacotherapy of essential tremor : an overview of existing and upcoming agents.

Authors:  Kelly E Lyons; Rajesh Pahwa
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

3.  Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor.

Authors:  Dietrich Haubenberger; Daniel Kalowitz; Fatta B Nahab; Camilo Toro; Dominic Ippolito; David A Luckenbaugh; Loretta Wittevrongel; Mark Hallett
Journal:  Mov Disord       Date:  2011-06-28       Impact factor: 10.338

4.  The Effect of Octanoic Acid on Essential Voice Tremor: A Double-Blind, Placebo-Controlled Study.

Authors:  Soren Y Lowell; Richard T Kelley; Marika Monahan; Carly Jo Hosbach-Cannon; Raymond H Colton; Dragos Mihaila
Journal:  Laryngoscope       Date:  2018-12-25       Impact factor: 3.325

5.  T-type calcium channel antagonists suppress tremor in two mouse models of essential tremor.

Authors:  Adrian Handforth; Gregg E Homanics; Douglas F Covey; Kathiresan Krishnan; Jae Yeol Lee; Kenji Sakimura; Fredricka C Martin; Arnulfo Quesada
Journal:  Neuropharmacology       Date:  2010-06-12       Impact factor: 5.250

6.  pH-dependent modulation of connexin-based gap junctional uncouplers.

Authors:  Vytenis A Skeberdis; Lina Rimkute; Aiste Skeberdyte; Nerijus Paulauskas; Feliksas F Bukauskas
Journal:  J Physiol       Date:  2011-05-23       Impact factor: 5.182

7.  The response of the central and peripheral tremor component to octanoic acid in patients with essential tremor.

Authors:  Hongmei Cao; Johanna Thompson-Westra; Mark Hallett; Dietrich Haubenberger
Journal:  Clin Neurophysiol       Date:  2018-04-03       Impact factor: 3.708

8.  Octanoic acid suppresses harmaline-induced tremor in mouse model of essential tremor.

Authors:  Fatta B Nahab; Adrian Handforth; Tyler Brown; Christopher Shin; Arnulfo Quesada; Chuanhui Dong; Dietrich Haubenberger; Mark Hallett
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

Review 9.  Pharmacological management of essential tremor.

Authors:  Reza Sadeghi; William G Ondo
Journal:  Drugs       Date:  2010-12-03       Impact factor: 9.546

10.  Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study.

Authors:  Dietrich Haubenberger; Gayle McCrossin; Codrin Lungu; Elaine Considine; Camilo Toro; Fatta B Nahab; Sungyoung Auh; Peter Buchwald; George J Grimes; Judith Starling; Gopal Potti; Linda Scheider; Daniel Kalowitz; Daniel Bowen; Andrea Carnie; Mark Hallett
Journal:  Neurology       Date:  2013-02-13       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.